Applied Therapeutics Inc logo

Applied Therapeutics Inc

€ 0.88 (+0.06%) Dec 2
P/E:
At Loss
P/B:
4.66
Market Cap:
€ 42.57M ($ 45.08M)
Enterprise V:
€ 2.00K ($ 2.00K)
Volume:
-
Avg Vol (2M):
1.60K
Also Trade In:
Volume:
-
Market Cap €:
42.57M
Market Cap $:
45.08M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.60K
Enterprise Value €:
2.00K
Enterprise Value $:
2.00K
PB Ratio:
4.66
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.
Name Current Vs Industry Vs History
Cash-To-Debt 18.51
Equity-to-Asset 0.17
Debt-to-Equity 0.27
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -40.7
3-Year EPS without NRI Growth Rate -31.8
3-Year FCF Growth Rate -42.7

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 69.87
9-Day RSI 62.92
14-Day RSI 50.98
6-1 Month Momentum % -93
12-1 Month Momentum % -93

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.19
Quick Ratio 1.19
Cash Ratio 1.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.4
Name Current Vs Industry Vs History
ROE % -210.11
ROA % -116.64
ROIC % -591.91
ROC (Joel Greenblatt) % -6562.82
ROCE % -197.6

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 4.66
Price-to-Tangible-Book 4.66
Price-to-Net-Current-Asset-Value 5.2
Price-to-Net-Cash 88.45

Financials (Next Earnings Date:2023-03-10 Est.)

FRA:2UV's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -3.031
Beta 1.07
Volatility % 90.92
14-Day RSI 50.98
14-Day ATR (€) 0.03239
20-Day SMA (€) 0.79965
12-1 Month Momentum % -93
52-Week Range (€) 0.638 - 12
Shares Outstanding (Mil) 48.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Applied Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Applied Therapeutics Inc Analysis

Share your research